Zepbound
- Product NDC
- 0002-6103
- 11-digit product format
- 000026103
- Labeler code
- 0002
- Product ID
- 0002-6103_86a64015-7f78-4281-8b7f-579b6c3dc1f7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tirzepatide
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Eli Lilly and Company
- Application
- NDA217806
- Marketing category
- NDA
- Marketing start
- 2026-01-07
- Substance
- TIRZEPATIDE
- Active strength
- 8.33 mg/mL
- Pharmacologic classes
- G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N217806-001 | ZEPBOUND (AUTOINJECTOR) | TIRZEPATIDE | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | |
| N217806-002 | ZEPBOUND (AUTOINJECTOR) | TIRZEPATIDE | 5MG/0.5ML (5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | |
| N217806-003 | ZEPBOUND (AUTOINJECTOR) | TIRZEPATIDE | 7.5MG/0.5ML (7.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | |
| N217806-004 | ZEPBOUND (AUTOINJECTOR) | TIRZEPATIDE | 10MG/0.5ML (10MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | |
| N217806-005 | ZEPBOUND (AUTOINJECTOR) | TIRZEPATIDE | 12.5MG/0.5ML (12.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | |
| N217806-006 | ZEPBOUND (AUTOINJECTOR) | TIRZEPATIDE | 15MG/0.5ML (15MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | |
| N217806-007 | ZEPBOUND | TIRZEPATIDE | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | |
| N217806-008 | ZEPBOUND | TIRZEPATIDE | 5MG/0.5ML (5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | |
| N217806-009 | ZEPBOUND | TIRZEPATIDE | 7.5MG/0.5ML (7.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | |
| N217806-010 | ZEPBOUND | TIRZEPATIDE | 10MG/0.5ML (10MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | |
| N217806-011 | ZEPBOUND | TIRZEPATIDE | 12.5MG/0.5ML (12.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | |
| N217806-012 | ZEPBOUND | TIRZEPATIDE | 15MG/0.5ML (15MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | |
| N217806-013 | ZEPBOUND | TIRZEPATIDE | 10MG/2.4ML (4.17MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | |
| N217806-014 | ZEPBOUND | TIRZEPATIDE | 20MG/2.4ML (8.33MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | |
| N217806-015 | ZEPBOUND | TIRZEPATIDE | 30MG/2.4ML (12.5MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | |
| N217806-016 | ZEPBOUND | TIRZEPATIDE | 40MG/2.4ML (16.7MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | |
| N217806-017 | ZEPBOUND | TIRZEPATIDE | 50MG/2.4ML (20.8MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | |
| N217806-018 | ZEPBOUND | TIRZEPATIDE | 60MG/2.4ML (25MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | |
| N217806-019 | ZEPBOUND KWIKPEN | TIRZEPATIDE | 10MG/2.4ML (4.17MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 | |
| N217806-020 | ZEPBOUND KWIKPEN | TIRZEPATIDE | 20MG/2.4ML (8.33MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 | |
| N217806-021 | ZEPBOUND KWIKPEN | TIRZEPATIDE | 30MG/2.4ML (12.5MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 | |
| N217806-022 | ZEPBOUND KWIKPEN | TIRZEPATIDE | 40MG/2.4ML (16.7MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 | |
| N217806-023 | ZEPBOUND KWIKPEN | TIRZEPATIDE | 50MG/2.4ML (20.8MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 | |
| N217806-024 | ZEPBOUND KWIKPEN | TIRZEPATIDE | 60MG/2.4ML (25MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N217806-001 | 9474780 | 2036-05-13 | Drug substance, Drug product | 2023-12-07 | |
| N217806-001 | 11357820 | 2039-06-14 | Drug product | 2023-12-07 | |
| N217806-001 | 11918623 | 2039-06-14 | U-3855 | 2024-03-28 | |
| N217806-001 | 12453756 | 2039-06-14 | Drug product | 2025-11-17 | |
| N217806-001 | 12629404 | 2039-06-14 | U-4531 | Drug product | 2026-06-05 |
| N217806-001 | 12629404 | 2039-06-14 | U-4532 | Drug product | 2026-06-05 |
| N217806-001 | 12343382 | 2039-07-22 | U-4227 | 2025-07-25 | |
| N217806-001 | 12343382 | 2039-07-22 | U-4228 | 2025-07-25 | |
| N217806-001 | 12343382 | 2039-07-22 | U-4409 | 2025-07-25 | |
| N217806-001 | 12343382 | 2039-07-22 | U-4410 | 2025-07-25 | |
| N217806-001 | 12453758 | 2039-07-22 | U-4308 | 2025-11-17 | |
| N217806-001 | 12453758 | 2039-07-22 | U-4309 | 2025-11-17 | |
| N217806-001 | 12453758 | 2039-07-22 | U-4310 | 2025-11-17 | |
| N217806-001 | 12453758 | 2039-07-22 | U-4311 | 2025-11-17 | |
| N217806-001 | 12616740 | 2039-07-22 | U-4497 | 2026-05-05 | |
| N217806-001 | 12616740 | 2039-07-22 | U-4498 | 2026-05-05 | |
| N217806-001 | 12616740 | 2039-07-22 | U-4499 | 2026-05-05 | |
| N217806-002 | 9474780 | 2036-05-13 | Drug substance, Drug product | 2023-12-07 | |
| N217806-002 | 11357820 | 2039-06-14 | Drug product | 2023-12-07 | |
| N217806-002 | 11918623 | 2039-06-14 | U-3855 | 2024-03-28 | |
| N217806-002 | 12453756 | 2039-06-14 | Drug product | 2025-11-17 | |
| N217806-002 | 12629404 | 2039-06-14 | U-4531 | Drug product | 2026-06-05 |
| N217806-002 | 12629404 | 2039-06-14 | U-4532 | Drug product | 2026-06-05 |
| N217806-002 | 12343382 | 2039-07-22 | U-4227 | 2025-07-25 | |
| N217806-002 | 12343382 | 2039-07-22 | U-4228 | 2025-07-25 | |
| N217806-002 | 12343382 | 2039-07-22 | U-4409 | 2025-07-25 | |
| N217806-002 | 12343382 | 2039-07-22 | U-4410 | 2025-07-25 | |
| N217806-002 | 12453758 | 2039-07-22 | U-4308 | 2025-11-17 | |
| N217806-002 | 12453758 | 2039-07-22 | U-4309 | 2025-11-17 | |
| N217806-002 | 12453758 | 2039-07-22 | U-4310 | 2025-11-17 | |
| N217806-002 | 12453758 | 2039-07-22 | U-4311 | 2025-11-17 | |
| N217806-002 | 12616740 | 2039-07-22 | U-4497 | 2026-05-05 | |
| N217806-002 | 12616740 | 2039-07-22 | U-4498 | 2026-05-05 | |
| N217806-002 | 12616740 | 2039-07-22 | U-4499 | 2026-05-05 | |
| N217806-003 | 9474780 | 2036-05-13 | Drug substance, Drug product | 2023-12-07 | |
| N217806-003 | 11357820 | 2039-06-14 | Drug product | 2023-12-07 | |
| N217806-003 | 11918623 | 2039-06-14 | U-3855 | 2024-03-28 | |
| N217806-003 | 12453756 | 2039-06-14 | Drug product | 2025-11-17 | |
| N217806-003 | 12629404 | 2039-06-14 | U-4531 | Drug product | 2026-06-05 |
| N217806-003 | 12629404 | 2039-06-14 | U-4532 | Drug product | 2026-06-05 |
| N217806-003 | 12343382 | 2039-07-22 | U-4227 | 2025-07-25 | |
| N217806-003 | 12343382 | 2039-07-22 | U-4228 | 2025-07-25 | |
| N217806-003 | 12343382 | 2039-07-22 | U-4409 | 2025-07-25 | |
| N217806-003 | 12343382 | 2039-07-22 | U-4410 | 2025-07-25 | |
| N217806-003 | 12453758 | 2039-07-22 | U-4308 | 2025-11-17 | |
| N217806-003 | 12453758 | 2039-07-22 | U-4309 | 2025-11-17 | |
| N217806-003 | 12453758 | 2039-07-22 | U-4310 | 2025-11-17 | |
| N217806-003 | 12453758 | 2039-07-22 | U-4311 | 2025-11-17 | |
| N217806-003 | 12616740 | 2039-07-22 | U-4497 | 2026-05-05 | |
| N217806-003 | 12616740 | 2039-07-22 | U-4498 | 2026-05-05 | |
| N217806-003 | 12616740 | 2039-07-22 | U-4499 | 2026-05-05 | |
| N217806-004 | 9474780 | 2036-05-13 | Drug substance, Drug product | 2023-12-07 | |
| N217806-004 | 11357820 | 2039-06-14 | Drug product | 2023-12-07 | |
| N217806-004 | 11918623 | 2039-06-14 | U-3855 | 2024-03-28 | |
| N217806-004 | 12453756 | 2039-06-14 | Drug product | 2025-11-17 | |
| N217806-004 | 12629404 | 2039-06-14 | U-4531 | Drug product | 2026-06-05 |
| N217806-004 | 12629404 | 2039-06-14 | U-4532 | Drug product | 2026-06-05 |
| N217806-004 | 12343382 | 2039-07-22 | U-4227 | 2025-07-25 | |
| N217806-004 | 12343382 | 2039-07-22 | U-4228 | 2025-07-25 | |
| N217806-004 | 12343382 | 2039-07-22 | U-4409 | 2025-07-25 | |
| N217806-004 | 12343382 | 2039-07-22 | U-4410 | 2025-07-25 | |
| N217806-004 | 12453758 | 2039-07-22 | U-4308 | 2025-11-17 | |
| N217806-004 | 12453758 | 2039-07-22 | U-4309 | 2025-11-17 | |
| N217806-004 | 12453758 | 2039-07-22 | U-4310 | 2025-11-17 | |
| N217806-004 | 12453758 | 2039-07-22 | U-4311 | 2025-11-17 | |
| N217806-004 | 12616740 | 2039-07-22 | U-4497 | 2026-05-05 | |
| N217806-004 | 12616740 | 2039-07-22 | U-4498 | 2026-05-05 | |
| N217806-004 | 12616740 | 2039-07-22 | U-4499 | 2026-05-05 | |
| N217806-005 | 9474780 | 2036-05-13 | Drug substance, Drug product | 2023-12-07 | |
| N217806-005 | 11357820 | 2039-06-14 | Drug product | 2023-12-07 | |
| N217806-005 | 11918623 | 2039-06-14 | U-3855 | 2024-03-28 | |
| N217806-005 | 12453756 | 2039-06-14 | Drug product | 2025-11-17 | |
| N217806-005 | 12629404 | 2039-06-14 | U-4531 | Drug product | 2026-06-05 |
| N217806-005 | 12629404 | 2039-06-14 | U-4532 | Drug product | 2026-06-05 |
| N217806-005 | 12343382 | 2039-07-22 | U-4227 | 2025-07-25 | |
| N217806-005 | 12343382 | 2039-07-22 | U-4228 | 2025-07-25 | |
| N217806-005 | 12343382 | 2039-07-22 | U-4409 | 2025-07-25 | |
| N217806-005 | 12343382 | 2039-07-22 | U-4410 | 2025-07-25 | |
| N217806-005 | 12453758 | 2039-07-22 | U-4308 | 2025-11-17 | |
| N217806-005 | 12453758 | 2039-07-22 | U-4309 | 2025-11-17 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N217806-001 | NP | 2026-11-08 |
| N217806-001 | NCE | 2027-05-13 |
| N217806-001 | M-82 | 2027-10-18 |
| N217806-001 | I-958 | 2027-12-20 |
| N217806-002 | NP | 2026-11-08 |
| N217806-002 | NCE | 2027-05-13 |
| N217806-002 | M-82 | 2027-10-18 |
| N217806-002 | I-958 | 2027-12-20 |
| N217806-003 | NP | 2026-11-08 |
| N217806-003 | NCE | 2027-05-13 |
| N217806-003 | M-82 | 2027-10-18 |
| N217806-003 | I-958 | 2027-12-20 |
| N217806-004 | NP | 2026-11-08 |
| N217806-004 | NCE | 2027-05-13 |
| N217806-004 | M-82 | 2027-10-18 |
| N217806-004 | I-958 | 2027-12-20 |
| N217806-005 | NP | 2026-11-08 |
| N217806-005 | NCE | 2027-05-13 |
| N217806-005 | M-82 | 2027-10-18 |
| N217806-005 | I-958 | 2027-12-20 |
| N217806-006 | NP | 2026-11-08 |
| N217806-006 | NCE | 2027-05-13 |
| N217806-006 | M-82 | 2027-10-18 |
| N217806-006 | I-958 | 2027-12-20 |
| N217806-007 | NCE | 2027-05-13 |
| N217806-007 | M-82 | 2027-10-18 |
| N217806-007 | I-958 | 2027-12-20 |
| N217806-008 | NCE | 2027-05-13 |
| N217806-008 | M-82 | 2027-10-18 |
| N217806-008 | I-958 | 2027-12-20 |
| N217806-009 | NCE | 2027-05-13 |
| N217806-009 | M-82 | 2027-10-18 |
| N217806-009 | I-958 | 2027-12-20 |
| N217806-010 | NCE | 2027-05-13 |
| N217806-010 | M-82 | 2027-10-18 |
| N217806-010 | I-958 | 2027-12-20 |
| N217806-011 | NCE | 2027-05-13 |
| N217806-011 | M-82 | 2027-10-18 |
| N217806-011 | I-958 | 2027-12-20 |
| N217806-012 | NCE | 2027-05-13 |
| N217806-012 | M-82 | 2027-10-18 |
| N217806-012 | I-958 | 2027-12-20 |
| N217806-013 | NCE | 2027-05-13 |
| N217806-013 | M-82 | 2027-10-18 |
| N217806-013 | I-958 | 2027-12-20 |
| N217806-014 | NCE | 2027-05-13 |
| N217806-014 | M-82 | 2027-10-18 |
| N217806-014 | I-958 | 2027-12-20 |
| N217806-015 | NCE | 2027-05-13 |
| N217806-015 | M-82 | 2027-10-18 |
| N217806-015 | I-958 | 2027-12-20 |
| N217806-016 | NCE | 2027-05-13 |
| N217806-016 | M-82 | 2027-10-18 |
| N217806-016 | I-958 | 2027-12-20 |
| N217806-017 | NCE | 2027-05-13 |
| N217806-017 | M-82 | 2027-10-18 |
| N217806-017 | I-958 | 2027-12-20 |
| N217806-018 | NCE | 2027-05-13 |
| N217806-018 | M-82 | 2027-10-18 |
| N217806-018 | I-958 | 2027-12-20 |
| N217806-019 | NCE | 2027-05-13 |
| N217806-019 | M-82 | 2027-10-18 |
| N217806-019 | I-958 | 2027-12-20 |
| N217806-020 | NCE | 2027-05-13 |
| N217806-020 | M-82 | 2027-10-18 |
| N217806-020 | I-958 | 2027-12-20 |
| N217806-021 | NCE | 2027-05-13 |
| N217806-021 | M-82 | 2027-10-18 |
| N217806-021 | I-958 | 2027-12-20 |
| N217806-022 | NCE | 2027-05-13 |
| N217806-022 | M-82 | 2027-10-18 |
| N217806-022 | I-958 | 2027-12-20 |
| N217806-023 | NCE | 2027-05-13 |
| N217806-023 | M-82 | 2027-10-18 |
| N217806-023 | I-958 | 2027-12-20 |
| N217806-024 | NCE | 2027-05-13 |
| N217806-024 | M-82 | 2027-10-18 |
| N217806-024 | I-958 | 2027-12-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | ZEPBOUND (AUTOINJECTOR) | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | ZEPBOUND (AUTOINJECTOR) | 5MG/0.5ML (5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-003 | ZEPBOUND (AUTOINJECTOR) | 7.5MG/0.5ML (7.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-004 | ZEPBOUND (AUTOINJECTOR) | 10MG/0.5ML (10MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-005 | ZEPBOUND (AUTOINJECTOR) | 12.5MG/0.5ML (12.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-006 | ZEPBOUND (AUTOINJECTOR) | 15MG/0.5ML (15MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-007 | ZEPBOUND | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-008 | ZEPBOUND | 5MG/0.5ML (5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-009 | ZEPBOUND | 7.5MG/0.5ML (7.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-010 | ZEPBOUND | 10MG/0.5ML (10MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-011 | ZEPBOUND | 12.5MG/0.5ML (12.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-012 | ZEPBOUND | 15MG/0.5ML (15MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-013 | ZEPBOUND | 10MG/2.4ML (4.17MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-014 | ZEPBOUND | 20MG/2.4ML (8.33MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-015 | ZEPBOUND | 30MG/2.4ML (12.5MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-016 | ZEPBOUND | 40MG/2.4ML (16.7MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-017 | ZEPBOUND | 50MG/2.4ML (20.8MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-018 | ZEPBOUND | 60MG/2.4ML (25MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-019 | ZEPBOUND KWIKPEN | 10MG/2.4ML (4.17MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-020 | ZEPBOUND KWIKPEN | 20MG/2.4ML (8.33MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-021 | ZEPBOUND KWIKPEN | 30MG/2.4ML (12.5MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-022 | ZEPBOUND KWIKPEN | 40MG/2.4ML (16.7MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-023 | ZEPBOUND KWIKPEN | 50MG/2.4ML (20.8MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-024 | ZEPBOUND KWIKPEN | 60MG/2.4ML (25MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-20 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-001 | ZEPBOUND (AUTOINJECTOR) | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-002 | ZEPBOUND (AUTOINJECTOR) | 5MG/0.5ML (5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-003 | ZEPBOUND (AUTOINJECTOR) | 7.5MG/0.5ML (7.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-004 | ZEPBOUND (AUTOINJECTOR) | 10MG/0.5ML (10MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-005 | ZEPBOUND (AUTOINJECTOR) | 12.5MG/0.5ML (12.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-006 | ZEPBOUND (AUTOINJECTOR) | 15MG/0.5ML (15MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2023-11-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-007 | ZEPBOUND | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-008 | ZEPBOUND | 5MG/0.5ML (5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-009 | ZEPBOUND | 7.5MG/0.5ML (7.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-010 | ZEPBOUND | 10MG/0.5ML (10MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-011 | ZEPBOUND | 12.5MG/0.5ML (12.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-012 | ZEPBOUND | 15MG/0.5ML (15MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2024-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-013 | ZEPBOUND | 10MG/2.4ML (4.17MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-014 | ZEPBOUND | 20MG/2.4ML (8.33MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-015 | ZEPBOUND | 30MG/2.4ML (12.5MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217806-016 | ZEPBOUND | 40MG/2.4ML (16.7MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-01-07 | 011fe1cb6892… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 9474780 | 2036-05-13 | Drug substance, Drug product | 2023-12-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 11357820 | 2039-06-14 | Drug product | 2023-12-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 11918623 | 2039-06-14 | U-3855 | 2024-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12453756 | 2039-06-14 | Drug product | 2025-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12629404 | 2039-06-14 | U-4531 | Drug product | 2026-06-05 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12629404 | 2039-06-14 | U-4532 | Drug product | 2026-06-05 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12343382 | 2039-07-22 | U-4228 | 2025-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12343382 | 2039-07-22 | U-4227 | 2025-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12343382 | 2039-07-22 | U-4409 | 2025-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12343382 | 2039-07-22 | U-4410 | 2025-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12453758 | 2039-07-22 | U-4308 | 2025-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12453758 | 2039-07-22 | U-4311 | 2025-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12453758 | 2039-07-22 | U-4310 | 2025-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12453758 | 2039-07-22 | U-4309 | 2025-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12616740 | 2039-07-22 | U-4497 | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12616740 | 2039-07-22 | U-4498 | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | 12616740 | 2039-07-22 | U-4499 | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 9474780 | 2036-05-13 | Drug substance, Drug product | 2023-12-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 11357820 | 2039-06-14 | Drug product | 2023-12-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 11918623 | 2039-06-14 | U-3855 | 2024-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12453756 | 2039-06-14 | Drug product | 2025-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12629404 | 2039-06-14 | U-4531 | Drug product | 2026-06-05 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12629404 | 2039-06-14 | U-4532 | Drug product | 2026-06-05 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12343382 | 2039-07-22 | U-4228 | 2025-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12343382 | 2039-07-22 | U-4227 | 2025-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12343382 | 2039-07-22 | U-4410 | 2025-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12343382 | 2039-07-22 | U-4409 | 2025-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12453758 | 2039-07-22 | U-4311 | 2025-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12453758 | 2039-07-22 | U-4310 | 2025-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12453758 | 2039-07-22 | U-4309 | 2025-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12453758 | 2039-07-22 | U-4308 | 2025-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12616740 | 2039-07-22 | U-4497 | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12616740 | 2039-07-22 | U-4498 | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | 12616740 | 2039-07-22 | U-4499 | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-003 | 9474780 | 2036-05-13 | Drug substance, Drug product | 2023-12-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-003 | 11357820 | 2039-06-14 | Drug product | 2023-12-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-003 | 11918623 | 2039-06-14 | U-3855 | 2024-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-003 | 12453756 | 2039-06-14 | Drug product | 2025-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217806-003 | 12629404 | 2039-06-14 | U-4531 | Drug product | 2026-06-05 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-003 | 12629404 | 2039-06-14 | U-4532 | Drug product | 2026-06-05 | caaa826d4ba7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | NP | 2026-11-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | NCE | 2027-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | M-82 | 2027-10-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-001 | I-958 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | NP | 2026-11-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | NCE | 2027-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | M-82 | 2027-10-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-002 | I-958 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-003 | NP | 2026-11-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-003 | NCE | 2027-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-003 | M-82 | 2027-10-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-003 | I-958 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-004 | NP | 2026-11-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-004 | NCE | 2027-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-004 | M-82 | 2027-10-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-004 | I-958 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-005 | NP | 2026-11-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-005 | NCE | 2027-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-005 | M-82 | 2027-10-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-005 | I-958 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-006 | NP | 2026-11-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-006 | NCE | 2027-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-006 | M-82 | 2027-10-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-006 | I-958 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-007 | NCE | 2027-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-007 | M-82 | 2027-10-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-007 | I-958 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-008 | NCE | 2027-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-008 | M-82 | 2027-10-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-008 | I-958 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-009 | NCE | 2027-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-009 | M-82 | 2027-10-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-009 | I-958 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-010 | NCE | 2027-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-010 | M-82 | 2027-10-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-010 | I-958 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-011 | NCE | 2027-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-011 | M-82 | 2027-10-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-011 | I-958 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217806-012 | NCE | 2027-05-13 | caaa826d4ba7… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Zepbound
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TIRZEPATIDE | 8.33 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| OYN3CCI6QE | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2601743 | Internal RxNorm lookup |
| 2601755 | Internal RxNorm lookup |
| 2601761 | Internal RxNorm lookup |
| 2601767 | Internal RxNorm lookup |
| 2601773 | Internal RxNorm lookup |
| 2601784 | Internal RxNorm lookup |
| 2644396 | Internal RxNorm lookup |
| 2644401 | Internal RxNorm lookup |
| 2644405 | Internal RxNorm lookup |
| 2644409 | Internal RxNorm lookup |
| 2644413 | Internal RxNorm lookup |
| 2644417 | Internal RxNorm lookup |
| 2669706 | Internal RxNorm lookup |
| 2669709 | Internal RxNorm lookup |
| 2669712 | Internal RxNorm lookup |
| 2669715 | Internal RxNorm lookup |
| 2669718 | Internal RxNorm lookup |
| 2669721 | Internal RxNorm lookup |
| 2679317 | Internal RxNorm lookup |
| 2679319 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 487cd7e7-434c-4925-99fa-aa80b1cc776b | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 764832a6-c731-479b-b340-b4c8813a2a29 | Product name | 1 | 20250724 |
| 079c774f-6797-40bd-b11b-fd311f893a4e | Product name | 1 | 20230124 |
| 9869efd7-d6dd-0665-5b67-53adbe6ef15e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0002-6103-01 | Zepbound | 2.4 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 2.4 | 38 | |
| 0002-6103-11 | Zepbound | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 38 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zepbound | TIRZEPATIDE | Eli Lilly and Company | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | 217806 NDA217806 0002-6103 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2601767 | tirzepatide 10 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2644417 | tirzepatide 10 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734628 | tirzepatide 10 MG per dose (40 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2601773 | tirzepatide 12.5 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2644413 | tirzepatide 12.5 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734632 | tirzepatide 12.5 MG per dose (50 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732437 | tirzepatide 12.5 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2601755 | tirzepatide 15 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2644409 | tirzepatide 15 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734636 | tirzepatide 15 MG per dose (60 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732442 | tirzepatide 16.7 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2601761 | tirzepatide 2.5 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2644405 | tirzepatide 2.5 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734640 | tirzepatide 2.5 MG per dose (10 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732446 | tirzepatide 20.8 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732449 | tirzepatide 25 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732452 | tirzepatide 4.17 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2601743 | tirzepatide 5 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2644401 | tirzepatide 5 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734644 | tirzepatide 5 MG per dose (20 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2601784 | tirzepatide 7.5 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2644396 | tirzepatide 7.5 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734623 | tirzepatide 7.5 MG per dose (30 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732456 | tirzepatide 8.33 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669715 | zepbound 10 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679317 | zepbound 10 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734630 | zepbound 10 MG per dose (40 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669718 | zepbound 12.5 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679319 | zepbound 12.5 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734634 | zepbound 12.5 MG per dose (50 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732440 | zepbound 12.5 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669721 | zepbound 15 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679321 | zepbound 15 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734638 | zepbound 15 MG per dose (60 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732444 | zepbound 16.7 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669706 | zepbound 2.5 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679323 | zepbound 2.5 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734642 | zepbound 2.5 MG per dose (10 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732448 | zepbound 20.8 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732450 | zepbound 25 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732454 | zepbound 4.17 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669709 | zepbound 5 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679325 | zepbound 5 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734646 | Zepbound 5 MG per dose (20 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669712 | zepbound 7.5 MG in 0.5 ML Auto-Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679327 | zepbound 7.5 MG in 0.5 ML Injection | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734626 | zepbound 7.5 MG per dose (30 MG in 2.4 ML) Pen Injector | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732458 | zepbound 8.33 MG/ML Injectable Solution | PSN | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669709 | 0.5 ML tirzepatide 10 MG/ML Auto-Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679325 | 0.5 ML tirzepatide 10 MG/ML Injection [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669712 | 0.5 ML tirzepatide 15 MG/ML Auto-Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679327 | 0.5 ML tirzepatide 15 MG/ML Injection [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669715 | 0.5 ML tirzepatide 20 MG/ML Auto-Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679317 | 0.5 ML tirzepatide 20 MG/ML Injection [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669718 | 0.5 ML tirzepatide 25 MG/ML Auto-Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679319 | 0.5 ML tirzepatide 25 MG/ML Injection [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669721 | 0.5 ML tirzepatide 30 MG/ML Auto-Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679321 | 0.5 ML tirzepatide 30 MG/ML Injection [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2669706 | 0.5 ML tirzepatide 5 MG/ML Auto-Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2679323 | 0.5 ML tirzepatide 5 MG/ML Injection [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734626 | 2.4 ML tirzepatide 12.5 MG/ML Pen Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734630 | 2.4 ML tirzepatide 16.7 MG/ML Pen Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734634 | 2.4 ML tirzepatide 20.8 MG/ML Pen Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734638 | 2.4 ML tirzepatide 25 MG/ML Pen Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734642 | 2.4 ML tirzepatide 4.17 MG/ML Pen Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2734646 | 2.4 ML tirzepatide 8.33 MG/ML Pen Injector [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732440 | tirzepatide 12.5 MG/ML Injectable Solution [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732444 | tirzepatide 16.7 MG/ML Injectable Solution [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732448 | tirzepatide 20.8 MG/ML Injectable Solution [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732450 | tirzepatide 25 MG/ML Injectable Solution [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732454 | tirzepatide 4.17 MG/ML Injectable Solution [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2732458 | tirzepatide 8.33 MG/ML Injectable Solution [Zepbound] | SBD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2601743 | 0.5 ML tirzepatide 10 MG/ML Auto-Injector | SCD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2644401 | 0.5 ML tirzepatide 10 MG/ML Injection | SCD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2601784 | 0.5 ML tirzepatide 15 MG/ML Auto-Injector | SCD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2644396 | 0.5 ML tirzepatide 15 MG/ML Injection | SCD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2601767 | 0.5 ML tirzepatide 20 MG/ML Auto-Injector | SCD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2644417 | 0.5 ML tirzepatide 20 MG/ML Injection | SCD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2601773 | 0.5 ML tirzepatide 25 MG/ML Auto-Injector | SCD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
| 2644413 | 0.5 ML tirzepatide 25 MG/ML Injection | SCD | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 38 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0002-6103-01 | 00002610301 | 2.4 mL in 1 VIAL, MULTI-DOSE | 2.4 ml | Historical | |||
| 0002-6103-11 | 00002610311 | 1 VIAL, MULTI-DOSE in 1 CARTON (0002-6103-11) / 2.4 mL in 1 VIAL, MULTI-DOSE (0002-6103-01) | 2026-01-07 | No | No | Current |